Clinical Trials on Solid Cancers in Hungary

Total 705 results

Merck Sharp & Dohme LLC
Eisai Inc.

Active, not recruiting

A Study of Lenvatinib (MK-7902) in Pediatric Participants With Relapsed or Refractory Solid Malignancies (MK-7902-013/E7080) (E7080-G000-231)

Relapsed or Refractory Solid Tumors

United States, Argentina, Australia, Belgium, Croatia, Czechia, France, Guatemala, Hungary, Israel, Italy, Korea, Republic of, New Zealand, Peru, Russian Federation, Serbia, South Africa, Spain, Sweden, Turkey
AstraZeneca

Completed

Quality of Life Analysis of Arimidex Treatment in Postmenopausal Patients With Breast Cancer (RADAR II E)

Breast Cancer

Hungary
NantCell, Inc.
Takeda

Terminated

QUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas (GAMMA)

Cancer | Pancreatic Cancer | Advanced Solid Tumors | Metastatic Cancer | Bone Metastases | Solid Tumors | Pancreas Cancer | Adenocarcinoma of the Pancreas | Oncology | Cancer of Pancreas | Metastatic Pancreatic Cancer | Metastases | Cancer of the Pancreas | Advanced Malignancy | Oncology Patients | Endocrine Cancer

Italy, Spain, United Kingdom, Belgium, Canada, Denmark, Romania, United States, Germany, Netherlands, Korea, Republic of, Russian Federation, Australia, Austria, Lithuania, Portugal, Greece, Poland, Switzerland, Serbia, Bulgaria, ... and more
Epigenomics, Inc

Completed

Detection of Colorectal Cancer in Peripheral Blood by Septin 9 DNA Methylation Assay

Colorectal Cancer

Hungary, Germany
Novartis

Completed

Assessment of Pain and Quality of Life in Breast and Prostate Cancer Patients With Bone Metastases

Neoplasm Metastasis

Hungary
Bayer

No longer available

Expanded Access to Provide Copanlisib for Patients With Cancer Who Are Experiencing a Positive Response, as Determined by Their Doctors

Cancer

Brazil, Hong Kong, Hungary, Malaysia, Poland, Romania, Russian Federation, Taiwan, Ukraine, Ireland, Chile
Central European Cooperative Oncology Group

Completed

Dose Density FU 75 and FU 90 as Adjuvant Therapy for Early Breast Cancer

Breast Cancer

Austria, Hungary, Poland, Slovakia
Ludwig-Maximilians - University of Munich

Unknown

Combination Chemotherapy With or Without Whole-Body Hyperthermia in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity Cancer

Germany, Netherlands, Hungary
ETOP IBCSG Partners Foundation
National Cancer Institute (NCI); Breast International Group

Terminated

Premenopausal Endocrine Responsive Chemotherapy Trial (PERCHE)

Breast Cancer

Switzerland, Italy, Hungary
Pfizer
Hospira, now a wholly owned subsidiary of Pfizer

Completed

A Study Of The Safety And Effects Of One Or More Doses Of HSP-130 Injected Under The Skin In Women With Breast Cancer That Has Not Spread To Distant Sites In The Body.

Non-metastatic Breast Cancer

Hungary, Spain
Novartis Pharmaceuticals

Completed

Phase I/II Study of PDR001 in Patients With Advanced Malignancies

Melanoma | Triple Negative Breast Cancer | Anaplastic Thyroid Cancer | Other Solid Tumors | Non-small Sell Lung Cancer (NSCLC)

United States, Italy, Spain, Hungary, Taiwan, Germany, Netherlands, France, Norway, Poland, Thailand, Lebanon, Turkey, Canada
Amgen

Completed

Dose/ Schedule Finding Trial of Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC)

Cancer | Lung Neoplasms | Non-Small Cell Lung Cancer | Thrombocytopenia | Lung Cancer | Solid Tumors | Oncology | Chemotherapy-Induced Thrombocytopenia

United States, Canada, Italy, Germany, Austria, Hungary, Portugal, Ireland
Amgen

Active, not recruiting

A Phase 1/2, Study Evaluating the Safety, Tolerability, PK, and Efficacy of Sotorasib (AMG 510) in Subjects With Solid Tumors With a Specific KRAS Mutation (CodeBreaK 100)

KRAS p.G12C Mutant Advanced Solid Tumors

United States, France, Canada, Spain, Belgium, Korea, Republic of, Austria, Australia, Hungary, Greece, Germany, Japan, Romania, Switzerland, Brazil, Portugal
Hoffmann-La Roche

Completed

XEBRA Study: An Observational Study of Xeloda (Capecitabine) in Combination With Docetaxel in First Line in Participants With HER2-Negative Metastatic Breast Cancer

Breast Cancer

Hungary
Turning Point Therapeutics, Inc.
Zai Lab (Shanghai) Co., Ltd.

Recruiting

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements (TRIDENT-1)

Locally Advanced Solid Tumors | Metastatic Solid Tumors

United States, China, Japan, Australia, Belgium, Canada, Denmark, France, Germany, Hong Kong, Hungary, Italy, Korea, Democratic People's Republic of, Korea, Republic of, Netherlands, Poland, Singapore, Spain, Taiwan, United Kingdom
Radboud University Medical Center
Icahn School of Medicine at Mount Sinai; KU Leuven; University of Sheffield; University... and other collaborators

Unknown

Patient-centred Integrated Palliative Care Pathways in Advanced Cancer and Chronic Disease (InSup-C)

Heart Failure | Cancer | COPD

Germany, Belgium, Hungary, Netherlands, United Kingdom
Transgene
Bristol-Myers Squibb

Completed

A Study Evaluating the Efficacy and the Safety of First-line Chemotherapy Combined With the Therapeutic Vaccine Named TG4010 and Nivolumab in Patients With Advanced Non-squamous Non-Small Cell Lung Cancer (NSCLC)

Non Small Cell Lung Cancer Metastatic

Hungary, France, United States, Belgium
ERYtech Pharma

Terminated

Study of Eryaspase in Combination With Chemotherapy Versus Chemotherapy Alone for the Treatment of TNBC (TRYbeCA-2)

Triple Negative Breast Cancer

Spain, Belgium, Hungary
AstraZeneca
Parexel; Iqvia Pty Ltd; Medidata Solutions; CISCRP

Active, not recruiting

Durvalumab Long-Term Safety and Efficacy Study (WAVE)

Solid Tumor

Spain, United Kingdom, United States, Canada, Czechia, Poland, Romania, Thailand, Vietnam, Belgium, France, Korea, Republic of, Brazil, Hungary, Japan, Russian Federation, Malaysia, Taiwan, Australia, Germany, Turkey, Ukraine, Nethe... and more
Advanced Medical Diagnostics s.a.

Completed

Prostate HistoScanning for the Non-invasive Detection and Staging of Prostate Cancer and Characterization of Prostate Tissues (PHS-02) (PHS-02)

Prostate Cancer

Germany, United Kingdom, Belgium, Czech Republic, Hungary
Genzyme, a Sanofi Company

Completed

E3 Breast Cancer Taxotere Combination

Advanced Breast Cancer

South Africa, Sweden, Hungary, Taiwan, Spain
Swiss Group for Clinical Cancer Research

Completed

External-Beam Radiation Therapy, Capecitabine, and Sorafenib in Treating Patients With Locally Advanced Rectal Cancer

Colorectal Cancer

Switzerland, Hungary
Hoffmann-La Roche

Completed

A Survey of Breast Cancer Patients With Metastatic Bone Disease Receiving Oral Ibandronate

Metastatic Breast Cancer

Hungary
Aziende Chimiche Riunite Angelini Francesco S.p.A
PPD

Completed

Benzydamine Oromucosal Solution in Oral Mucositis (BOOM) (BOOM)

Head and Neck Cancer | Radiation-Induced Mucositis

Hungary, Poland
University of Erlangen-Nürnberg Medical School

Unknown

APBI Versus EBRT Therapy After Breast Conserving Surgery for Low-risk Breast Cancer

Breast Cancer

Austria, Germany, Hungary, Poland, Spain
Takeda

Completed

A Clinical Trial With Intranasal Fentanyl in Cancer Patients With Breakthrough Pain (NOSE-400)

Cancer | Break Through Pain

Russian Federation, Hungary, Norway
Genmab

Completed

Zalutumumab Pharmacokinetics (PK) in Squamous Cell Carcinoma of the Head and Neck (SCCHN)

Head and Neck Cancer

United Kingdom, Belgium, Slovakia, Hungary
Sciensano
European Commission

Recruiting

Telerehabilitation and Tele-psychological Support in Cancer Patients eCAN JA (eCAN)

Cancer

Hungary, Greece, Belgium, Cyprus, Ireland, Italy, Lithuania, Portugal, Slovenia, Spain
Swiss Group for Clinical Cancer Research

Completed

Sorafenib Tosylate With or Without Everolimus in Treating Patients With Localized, Unresectable, or Metastatic Liver Cancer

Liver Cancer

Switzerland, Austria, Hungary
AstraZeneca

Recruiting

Ascending Doses of Ceralasertib in Combination With Chemotherapy and/or Novel Anti Cancer Agents

Adv Solid Malig - H&N SCC, ATM Pro / Def NSCLC, Gastric, Breast and Ovarian Cancer

Spain, United States, Belgium, United Kingdom, France, Hungary, Canada, Korea, Republic of, Australia
Swiss Group for Clinical Cancer Research

Completed

Capecitabine and Radiation Therapy With or Without Panitumumab in Treating Patients With Advanced Rectal Cancer

Colorectal Cancer

Switzerland, Hungary
European Organisation for Research and Treatment...

Completed

Irinotecan and Cisplatin in Treating Patients With Locally Advanced or Metastatic Penile Cancer

Penile Cancer

France, United Kingdom, Poland, Belgium, Netherlands, Hungary
Tufts Medical Center

Terminated

Intercontinental Multidisciplinary Registry and Treatment Optimization Study for Choroid Plexus Tumors

Brain Cancer | Choroid Plexus Tumors

United States, Hungary, New Zealand, Germany
Hoffmann-La Roche

Completed

An Observational Study in Patients With Breast Cancer and Bone Metastases Receiving Ibandronate (Bondronat)

Breast Cancer

Hungary
Grünenthal GmbH

Terminated

Tapentadol in Chronic Malignant Tumour Related Pain

Pain | Cancer | Chronic Pain

Bulgaria, Hungary, Moldova, Republic of, Poland, Romania, Russian Federation, Serbia
Owlstone Ltd

Recruiting

Diagnostic Accuracy Study for OWL-EVO1 as a Lung Cancer EVOC® Probe (Evolution Phase 2)

Lung Cancer

United Kingdom, Czechia, Hungary
Merck KGaA, Darmstadt, Germany

Completed

Study of Avelumab and Cetuximab Plus Gemcitabine and Cisplatin in Participants With NSCLC

Squamous Non-Small Cell Lung Cancer

Spain, Hungary, Serbia
AstraZeneca

Completed

A Phase II, Study to Determine the Preliminary Efficacy of Novel Combinations of Treatment in Patients With Platinum Refractory Extensive-Stage Small-Cell Lung Cancer

Platinum Refractory Extensive-Stage Small Cell Lung Carcinoma

Spain, Poland, Hungary, Ukraine, Germany
Incyte Corporation

Recruiting

A Study to Evaluate INCB099280 in Participants With Select Solid Tumors Who Are Immune Checkpoint Inhibitor Naive

Advanced Solid Tumor

Georgia, Greece, Turkey, Brazil, Romania, Serbia, South Africa, New Zealand, China, Hungary, Malaysia, Singapore
Genentech, Inc.

Recruiting

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-6036 Alone or in Combination in Participants With Advanced or Metastatic Solid Tumors With a KRAS G12C Mutation

Colorectal Cancer | Non-Small Cell Lung Cancer | Advanced Solid Tumors

United States, Korea, Republic of, Spain, United Kingdom, Brazil, Israel, New Zealand, Netherlands, Canada, Australia, Switzerland, Belgium, Italy, Norway, Poland, Hungary, Kenya, Russian Federation, Germany
Institut de Recherches Internationales Servier
ADIR, a Servier Group company

Terminated

Phase 3 Study of Futuximab/Modotuximab in Combination With Trifluridine/Tipiracil Versus Trifluridine/Tipiracil Single Agent in Participants With Previously Treated Metastatic Colorectal Cancer (COLSTAR)

Metastatic Colorectal Cancer

Denmark, Japan, Belgium, Finland, Hungary, United States
Gilead Sciences

Completed

Safety Study of 90Y-hMN14 to Treat Colorectal Cancer

Colorectal Neoplasms | Colorectal Cancer | Rectal Cancer | Colon Cancer | Colorectal Carcinoma | Colorectal Tumor

United States, Sweden, Germany, Hungary, Switzerland
Pfizer

Terminated

Study Evaluating Bosutinib-Letrozole Combination Versus Letrozole Alone In Post Menopausal Women With Breast Cancer

Breast Cancer

United States, Belgium, Hungary, China, Hong Kong, Poland, Singapore
Hoffmann-La Roche

Completed

AVAREG Study: An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Breast Cancer

Breast Cancer

Hungary
Hoffmann-La Roche

Completed

An Observational Study of Continued Bevacizumab Plus Chemotherapy Until First Progression in Participants With Metastatic Colorectal Cancer (CRC) (AVACONT)

Colorectal Cancer

Hungary
Institut de Recherches Internationales Servier
ADIR, a Servier Group company

Completed

Study of S 95005 in Combination With Oxaliplatin in Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

Austria, France, Hungary, United Kingdom, Italy, Germany, Spain
UCB Pharma

Completed

A Study of Paclitaxel/Carboplatin With or Without CDP791 in Patients With Lung Cancer

Carcinoma | Non-Squamous Non-Small-Cell Lung Cancer

Poland, Russian Federation, Hungary
Prestige Biopharma Limited

Completed

A Phase III Trial to Compare the Efficacy, Safety and Pharmacokinetics of HD201 to Herceptin® in HER2+ Early Breast Cancer Patients (TROIKA)

HER2 Positive Breast Cancer

Spain, Malaysia, Estonia, Hungary, Thailand, Belarus, Bulgaria, France, Georgia, Italy, Poland, Russian Federation, Ukraine
Hoffmann-La Roche

Completed

An Observational Study of First-Line Capecitabine Based Chemotherapy in Participants With Metastatic Colorectal Cancer (AXEL)

Colorectal Cancer

Hungary
Seagen Inc.
Genmab

Completed

Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors

Bladder Cancer | Cervix Cancer | Ovary Cancer | Esophagus Cancer | Endometrium Cancer | Prostate Cancer (CRPC) | Lung Cancer (NSCLC)

United States, United Kingdom, Belgium, Hungary, Denmark

Clinical Trials on Solid Cancers in Hungary

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Switzerland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations